Capital Market Strategies’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,580
Closed -$202K 145
2023
Q2
$202K Buy
+3,580
New +$197K 0.19% 132
2023
Q1
Sell
-4,391
Closed -$231K 83
2022
Q4
$231K Sell
4,391
-258
-6% -$13.1K 0.25% 112
2022
Q3
$219K Sell
4,649
-67
-1% -$3.48K 0.25% 110
2022
Q2
$238K Sell
4,716
-152
-3% -$8.28K 0.25% 111
2022
Q1
$297K Sell
4,868
-2,187
-31% -$130K 0.26% 102
2021
Q4
$465K Buy
+7,055
New +$452K 0.38% 71

Other funds holding IHI

Capital Market Strategies's IHI Position: Q3 2023 in Review

Capital Market Strategies sold out of iShares US Medical Devices ETF (IHI) in Q3 2023, closing a stake of 3,580 shares — an estimated $202K sold.

Capital Market Strategies first reported a position in IHI in Q4 2021 and held it in 6 quarters. The position peaked at $465K in Q4 2021. 544 funds tracked by Wall St. Rank hold IHI as of Q3 2023.

  • Capital Market Strategies reported no remaining iShares US Medical Devices ETF position as of Q3 2023 after selling out during the quarter.
  • Capital Market Strategies sold 3,580 iShares US Medical Devices ETF shares in Q3 2023, an estimated $202K.
  • Capital Market Strategies first reported a position in iShares US Medical Devices ETF in Q4 2021 and held it in 6 quarters.
  • Capital Market Strategies's iShares US Medical Devices ETF position peaked at $465K in Q4 2021.
  • 544 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2023.

Based on Capital Market Strategies's 13F filing for Q3 2023, filed 18 Oct 2023.